Morning briefing — free market intel before the open

Kane Biotech Inc. (KNE)

Kane Biotech Inc. is a diversified issuer with ~12.8% warrant dilution and recent insider activity.

Price chart

KNE
Not enough data to draw a chart.
Open full chart →
Ticker
KNE
Exchange
TSXV
Primary commodity
diversified
Sector
mining
Shares outstanding
181,856,565
As of 2026-06-22

Warrant overhang

2 active warrant series covering 23,320,000 shares (~12.8% potential dilution); nearest expiry 2027-11-25.

View warrant overhang tool →

Dilution-true chart

Price history with the company's active warrant supply walls (amber) and free-trading unlock dates (violet) overlaid. Levels and dates are Pacific Time.

Loading chart…

Latest insider transaction

buyChristofalos, Lori Marlene (Senior Officer of Issuer)

1,500,000 shares ($75,000) on 2026-06-02.

View insider activity →

Recent news

No coverage yet for this ticker — it was recently added to our universe.

Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.

Chat